Cancer Research

Unibioscreen Secures Further Development Of Its Two Lead Compounds Into Clinical Phases

BRUSSELS, Belgium, March 4 /PRNewswire/-- Unibioscreen S.A., the Brussels specialist oncology company, is pleased to announce that it has succeeded in the closing of a new financing round of EUR 5 million from existing shareholders (ING, Société Générale ...

Article - Anna Ohlden - Mar 4 2008 - 4:30am

IGF-I Pathway Linked To Long Life In Centenarians

Mutations in genes governing an important cell-signaling pathway influence human longevity, scientists at the Albert Einstein College of Medicine of Yeshiva University have found. The report is the latest finding in the Einstein researchers’ ongoing search ...

Article - News Staff - Mar 4 2008 - 1:01pm

P53 Gene Discovery Could Lead To Treacher Collins Syndrome Being Treated In The Womb

Scientists have discovered how to prevent certain craniofacial disorders in what could ultimately lead to at-risk babies being treated in the womb. University of Manchester researchers, working with colleagues at the Stowers Institute for Medical Research ...

Article - News Staff - Mar 6 2008 - 6:22pm

27 Year Review Says Aspirin Could Help Prevent Breast Cancer

Anti-inflammatory drugs like aspirin may reduce breast cancer by up to 20 per cent, according to an extensive review carried out by experts at London’s Guy’s Hospital published in the International Journal of Clinical Practice. But they stress that further ...

Article - News Staff - Mar 6 2008 - 6:59pm

MC-Fold Makes 3D RNA From Sequence Data

A team of bioinformaticians at the Université de Montréal (UdeM) report in Nature the discovery of a structural alphabet that can be used to infer the 3D structure of ribonucleic acid (RNA) from sequence data, providing new tools to understand the role of ...

Article - News Staff - Mar 6 2008 - 4:53pm

Galderma Pharma, S.A. And ZARS Pharma, Inc. Extend Agreement To Cover Worldwide Rights For Pliaglis(TM)

LAUSANNE, Switzerland, March 7 /PRNewswire/-- Galderma Pharma, S.A. announces an agreement with ZARS Pharma, Inc. giving Galderma exclusive rights for all markets outside the USA and Canada for promotion and distribution of a novel topical anesthetic crea ...

Article - Anna Ohlden - Mar 7 2008 - 1:31pm

Lipid Molecule Research Could Lead To Better Allergy Medicines

A team of Penn State University researchers is the first to demonstrate that lipid molecules in cell membranes participate in mammals' reactions to allergens in a living cell. The finding will help scientists better understand how allergy symptoms are ...

Article - News Staff - Mar 8 2008 - 10:20am

Study: Gardasil HPV Vaccine Reduces Abnormal Pap Results

Nearly 25 million U.S. women between the ages of 14 and 59 are infected with HPV, and the annual cost of screening and treating cervical abnormalities is about $4 billion, according to a statement from the Society of Gynecologic Oncologists. For many unvac ...

Article - News Staff - Mar 10 2008 - 1:35am

Media Advisory- Oncolytics Biotech Inc. To Present At BioSquare 2008

CALGARY, Canada, March 10 /PRNewswire/-- Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the BioSquare 2008 Conference on Thursday, March 13, 2008. The event is ...

Article - Anna Ohlden - Mar 10 2008 - 12:30pm

Pyroptosis: How A Dying Cell Sounds An Alarm

Cells are coded with several programs for self-destruction. Many cells die peacefully. Others cause a ruckus on their way out. Some programmed cell death pathways simply and quietly remove unwanted cells, noted a team of University of Washington (UW) resea ...

Article - News Staff - Mar 10 2008 - 11:09pm